Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer Portfolio News / By admin November 29, 2018
NGM Bio Announces New Histology Data from Phase 2 Trial of NGM282 in Patients with NASH Portfolio News / By admin November 9, 2018
Arcus Biosciences Presents Initial Data from the Phase 1 Dose-Escalation Study of AB122, its anti-PD-1 antibody, at the SITC 2018 Annual Meeting Portfolio News / By admin November 9, 2018
NGM Bio Announces Multiple Presentations at AASLD’s The Liver Meeting®, Including New NASH Histology Data from the Phase 2 Trial of NGM282 and Topline Phase 1b Data for NGM313 Portfolio News / By admin November 6, 2018
Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of Myelofibrosis Portfolio News / By admin November 1, 2018
